Literature DB >> 9841845

Human herpesvirus 8: seroepidemiology among women and detection in the genital tract of seropositive women.

D Whitby1, N A Smith, S Matthews, S O'Shea, C A Sabin, R Kulasegaram, C Boshoff, R A Weiss, A de Ruiter, J M Best.   

Abstract

An indirect IFA to detect antibodies against latent nuclear antigens of human herpesvirus 8 (HHV-8) was used to determine the prevalence of HHV-8 antibodies in 169 women attending a sexually transmitted diseases clinic and a human immunodeficiency virus (HIV) clinic at a London hospital. Nested polymerase chain reaction was used to detect HHV-8 DNA in 93 blood samples and 89 cervical brush scrapes (CBS). Another 96 CBS from women attending a colposcopy clinic were also analyzed. The overall seroprevalence of HHV-8 was 18.3%. The seroprevalence was higher among women born in Africa (24.7%) than among women born elsewhere (11.5%; P=.06) and was independent of HIV serostatus. HHV-8 DNA was detected in 3 CBS and 6 peripheral blood samples from 11 HHV-8-seropositive women but not in CBS from 78 seronegative women, 96 women from the colposcopy clinic, or in blood samples from 82 seronegative women.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9841845     DOI: 10.1086/314563

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Pregnancy and human herpesvirus 8 reactivation in human immunodeficiency virus type 1-infected women.

Authors:  Andrea Lisco; Massimo Barbierato; Josè R Fiore; Paola Gasperini; Anna Favia; Anna Volpe; Maria Chironna; Giuseppe Pastore; Luigi Chieco-Bianchi; Maria Luisa Calabrò
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

2.  KSHV co-infection regulates HPV16+ cervical cancer cells pathogenesis in vitro and in vivo.

Authors:  Lu Dai; Jing Qiao; Luis Del Valle; Zhiqiang Qin
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

3.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

Review 4.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

5.  Activation of Kaposi's sarcoma-associated herpesvirus lytic gene expression during epithelial differentiation.

Authors:  Andrew S Johnson; Nicole Maronian; Jeffrey Vieira
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women.

Authors:  Melanie M Taylor; Bhavna Chohan; Ludo Lavreys; Wisal Hassan; Meei-Li Huang; Larry Corey; Rhoda Ashley Morrow; Barbra A Richardson; Kishorchandra Mandaliya; Jeckoniah Ndinya-Achola; Job Bwayo; Joan Kreiss
Journal:  J Infect Dis       Date:  2004-07-07       Impact factor: 5.226

7.  Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus.

Authors:  Scott A Tibbetts; Linda F van Dyk; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 8.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

Review 10.  KSHV co-infection, a new co-factor for HPV-related cervical carcinogenesis?

Authors:  Lu Dai; Mengmeng Zhao; Wei Jiang; Zhen Lin; Luis Del Valle; Zhiqiang Qin
Journal:  Am J Cancer Res       Date:  2018-11-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.